Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
51 Leser
Artikel bewerten:
(0)

Paul Thomas, Pharmaceutical Industry Sales & Commercial Manager, Joins Aegate as Regional Business Development Manager UK & Ireland

LONDON, January 12, 2015 /PRNewswire/ --

AEGATE, the leader in medicine verification and authentication services in the world, announced the appointment of Paul Thomas as Regional Business Development Manager UK & Ireland.

Paul brings a wealth of experience of and insight to the pharmaceutical industry and healthcare service provision, including product launches, strategic development and stakeholder engagement. Formerly he was Sales & Commercial Manager at Novo Nordisk for 13 years. He has worked in the UK, Ireland and the Nordic countries. "I'm delighted that Paul has joined Aegate, his knowledge and pharmaceutical experience will help us to build and deliver our services in the UK and Republic of Ireland," says Graham Smith, Commercial Director at Aegate.

Paul holds a Bachelor of Science in Biological Sciences from Manchester Metropolitan University and a Diploma in Strategic Management and Leadership from the Chartered Management Institute.

About Aegate

With a documented history of some 3 billion medicines scanned to date with an average rate of 200k transactions per hour across 15k dispensing points, Aegate is the principal active market leader in medicines verification. Aegate's Reach, Assure and Protect services meet the needs of all stakeholders. Supported internationally by manufacturers and pharmacists alike, Aegate is a European company with offices in Belgium, Italy, Switzerland and the UK. Our mission is to protect patients from falsified, recalled or expired medicines.

We operate a highly secure real-time system to verify the authenticity of medicines. This operates seamlessly from manufacturer to pharmacy, and fully meets the requirements of European legislation for falsified medicines. The Aegate network also supports messaging services that provide additional information for the pharmacist at the point of dispense, such as regulatory or drug safety advice and patient education or adherence information.

For more information on Aegate, please visit http://www.aegate.com

Mediacontact information:
Daniel Graham
Talkabout Group
Daniel@talkaboutgroup.co.uk
T: +447768-222280

CompanyContact:
Graham Smith
Commercial Director Aegate Ltd
Cambridge Technology Centre
Melbourn SG8 6DP UK
T: +44-1763-268160
M: +44-7785-748970
W: http://www.aegate.com


Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.